10don MSN
McKesson raises 2026 EPS guidance to $38.35–$38.85 while advancing oncology and specialty platforms
Discover key insights from McKesson’s Q2 2026 earnings call, including record growth, raised guidance, and strategic investments.
UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM ESTCompany ParticipantsBritt Vitalone - Executive VP ...
Healthcare distributor and services company McKesson (NYSE:MCK) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 10.1% year on year to $103.2 billion. Its non-GAAP profit of ...
Zacks.com on MSN
Will Strong Segmental Performance Drive MCK's Top Line in Q2?
McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.
It involves two new distribution centers that span nearly 1 million square feet and the expansion of another.
This quarter, analysts are expecting McKesson’s revenue to grow 11.2% year on year to $104.1 billion, slowing from the 21.3% ...
The Kiplinger Dividend 15 are poised to benefit as falling interest rates lure investors back to dividend-paying stocks.
The company will open two new distribution centers and expand a third as demand surges for GLP-1s and other refrigerated ...
After a 5-year break, Bryan Eisenberg returns to the global stage with a powerful keynote on why storytelling still wins in ...
Inventory management is now considered a prime candidate for automation as manufacturers target opportunities to reduce costs, accelerate product delivery and make the most out of experienced talent.
The Healthcare Claims Management Market is experiencing steady growth due to the rising adoption of automated claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results